Stereotactic Radiation in Vestibular Schwannoma
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date ICMJE | October 2, 2011 | ||||
Last Updated Date | October 6, 2011 | ||||
Start Date ICMJE | October 2011 | ||||
Estimated Primary Completion Date | October 2013 (final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE |
audiogram [ Time Frame: two year ] [ Designated as safety issue: Yes ] change from baseline audiogram at 6 months,1 year and 2 year |
||||
Original Primary Outcome Measures ICMJE | Same as current | ||||
Change History | Complete list of historical versions of study NCT01449604 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures ICMJE |
|
||||
Original Secondary Outcome Measures ICMJE | Same as current | ||||
Current Other Outcome Measures ICMJE | |||||
Original Other Outcome Measures ICMJE | |||||
Descriptive Information | |||||
Brief Title ICMJE | Stereotactic Radiation in Vestibular Schwannoma | ||||
Official Title ICMJE | Randomized Comparison of Steretotactic Radiosurgery and Hypofractionated Steretotactic Radiotherapy in the Treatment of Vestibular Schwannoma | ||||
Brief Summary | The purpose of this study is to determine whether stereotactic radiosurgery (SRS)and stereotactic radiotherapy (SRT)are effective in the treatment of vestibular schwannoma (VS). |
||||
Detailed Description | Vestibular schwannomas (VSs) are slow-growing tumors of the myelin-forming cells that cover cranial nerve VIII.The treatment options for patients with VSs include active observation, surgical management, and radiotherapy. However, the optimal treatment choice remain controversial. Over the past 10 years, there has been rapid progress in the application of stereotactic radiotherapy to the treatment of VSs. The stereotactic radiotherapy program includes single fraction radiosurgery (SRS) and hypofraction stereotactic radiotherapy (HSRT) are commonly used for VSs treatment. Since SRS and SRT techniques differ significantly enough to raise questions of therapeutic advantage and until now, there is no prospective, randomized study comparing the outcomes for patients treated using both radiotherapy techniques. We designed the first prospective randomized protocol to compare SRS and SRT for answer this question. |
||||
Study Type ICMJE | Interventional | ||||
Study Phase | Phase 3 | ||||
Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
||||
Condition ICMJE | Vestibular Schwannoma | ||||
Intervention ICMJE |
|
||||
Study Arm (s) |
|
||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Active, not recruiting | ||||
Estimated Enrollment ICMJE | 200 | ||||
Estimated Completion Date | October 2013 | ||||
Estimated Primary Completion Date | October 2013 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
Gender | Both | ||||
Ages | 18 Years to 80 Years | ||||
Accepts Healthy Volunteers | No | ||||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
Location Countries ICMJE | |||||
Administrative Information | |||||
NCT Number ICMJE | NCT01449604 | ||||
Other Study ID Numbers ICMJE | RAMART0111 | ||||
Has Data Monitoring Committee | No | ||||
Responsible Party | Putipun Puataweepong, Ramathibodi Hospital | ||||
Study Sponsor ICMJE | Ramathibodi Hospital | ||||
Collaborators ICMJE | |||||
Investigators ICMJE |
|
||||
Information Provided By | Ramathibodi Hospital | ||||
Verification Date | October 2011 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |